Rofuclav 250 mg is a combination antibiotic medication primarily used to treat various bacterial infections. It contains two active ingredients: Rofloxacin and Clavulanic acid. Rofloxacin is a broad-spectrum antibiotic that belongs to the class of fluoroquinolones, effective against a wide range of bacteria by inhibiting their DNA replication. Clavulanic acid, a beta-lactamase inhibitor, enhances the efficacy of Rofloxacin by preventing bacterial enzymes from neutralizing the antibiotic's effects. This combination is commonly prescribed for conditions such as respiratory tract infections, urinary tract infections, and skin infections, offering a potent solution against resistant bacterial strains. The 250 mg dosage is typically used in adults and children, depending on the severity of the infection, and is taken as directed by a healthcare provider to ensure proper therapeutic outcomes.